Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade
Pharmaceuticals · 10.06.2025 · 18 (6) · 867
DOI: 10.3390/ph18060867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.06.2025. Verfasst von Layla Bleibel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 309 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Background/Objectives: Depression ranks among the most prevalent mental health conditions globally, marked by a variety of symptoms that frequently cause significant emotional distress and impairment in individuals, alongside a high recurrence rate. The predominant approach to treating depression revolves around monoamine theory, utilizing SSRIs and SNRIs, with Esketamine emerging as a supplementary option in recent times. Nevertheless, there is a growing focus on exploring the relationship between inflammation and depression, revealing a strong correlation between the two. This insight prompts consideration of the anti-inflammatory properties of current antidepressants in their therapeutic application.
Methods
A systematic literature search was conducted using the PubMed database to identify randomized controlled trials (RCTs) and clinical trials (CTs) that assessed the in vivo anti-inflammatory effects of SSRIs (fluoxetine, escitalopram, sertraline, and paroxetine), the SNRI venlafaxine, and esketamine/ketamine in human subjects undergoing treatment for depression. The included studies were evaluated based on changes in levels of pro-inflammatory and anti-inflammatory markers in response to the antidepressant treatments.
Results
SSRIs, SNRIs, esketamine, and ketamine (a racemic mixture of S- and R-ketamine not formally approved for the treatment of depression) exhibit anti-inflammatory effects through diverse mechanisms, such as reducing pro-inflammatory cytokines or enhancing anti-inflammatory cytokines in serum or within specific brain regions like the hippocampus and prefrontal cortex. These actions are mediated through various inflammatory pathways, including nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), the brain Nod-like receptor pyrin-containing 3 (NLRP3) inflammasome, the glutamatergic system, the gut–brain axis, the hypothalamic–pituitary axis, impaired neuroplasticity, and the kynurenine pathway.
Conclusions
In summary, SSRIs, SNRIs, esketamine, and ketamine exert an anti-inflammatory role alongside their antidepressant effects via these intricate mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
- Department of Epidemiology and Public Health, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
- Department of Hospital Pharmacy, Medical University of Lodz, Muszyńskiego 1, 90-151 Lodz, Poland.
ORCID-Profile: Layla Bleibel, Gabriela Henrykowska, Anna Wiktorowska-Owczarek
Förderung
- Medical University of Lodz
Zitieren
APA
Bleibel, L., Sokołowska, P., Henrykowska, G., Owczarek, J., & Wiktorowska-Owczarek, A. (2025). Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade. Pharmaceuticals, 18(6), 867. https://doi.org/10.3390/ph18060867
Vancouver
Bleibel L, Sokołowska P, Henrykowska G, Owczarek J, Wiktorowska-Owczarek A. Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade. Pharmaceuticals. 2025;18(6):867. doi:10.3390/ph18060867
BibTeX
@article{Bleibel2025,
author = {Bleibel, Layla and Sokołowska, Paulina and Henrykowska, Gabriela and Owczarek, Jacek and Wiktorowska-Owczarek, Anna},
title = {Unveiling the Anti-Inflammatory Effects of Antidepressants: A Systematic Review of Human Studies over the Last Decade},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {6},
pages = {867},
doi = {10.3390/ph18060867}
}
EUVIMED